Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells
1988812 citationsVirginia M. Sanders, Rafael Fernandez-Botrán et al.profile →
CELL SURFACE IMMUNOGLOBULIN
1971335 citationsEllen S. Vitetta, Jonathan W. Uhr et al.The Journal of Experimental Medicineprofile →
Author Peers
Peers are selected by citation overlap in the author's most active subfields.
citations ·
hero ref
Countries citing papers authored by Ellen S. Vitetta
Since
Specialization
Citations
This map shows the geographic impact of Ellen S. Vitetta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen S. Vitetta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen S. Vitetta more than expected).
Fields of papers citing papers by Ellen S. Vitetta
This network shows the impact of papers produced by Ellen S. Vitetta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen S. Vitetta. The network helps show where Ellen S. Vitetta may publish in the future.
Co-authorship network of co-authors of Ellen S. Vitetta
This figure shows the co-authorship network connecting the top 25 collaborators of Ellen S. Vitetta.
A scholar is included among the top collaborators of Ellen S. Vitetta based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Ellen S. Vitetta. Ellen S. Vitetta is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Morgan, David, et al.. (2005). The anti-CD19 immunotoxin (HD37-dgRTA) is more effective when combined with chemotherapy. Cancer Research. 65. 162–162.2 indexed citations
Solomon, Scott R., Charles S. Carter, John Schindler, et al.. (2002). Optimized clinical-scale culture conditions for ex vivoselective depletion of host-reactive donor lymphocytes: astrategy for GVHD prophylaxis in allogeneic peripheral bloodstem cell transplantation. Cytotherapy. 4(5).1 indexed citations
7.
Uhr, Jonathan W., et al.. (2002). Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity of a human breast cancer cell line in vitro and in vivo.. PubMed. 8(6). 1720–30.138 indexed citations
8.
Michálek, Jaroslav, Robert H. Collins, Brenna J. Hill, Ellen S. Vitetta, & Daniel C. Douek. (2001). The Emergence of Specific T Cell Clones During the Generationof GVHD. Blood.1 indexed citations
9.
Vitetta, Ellen S. & Jonathan W. Uhr. (1994). Monoclonal antibodies as agonists: an expanded role for their use in cancer therapy.. PubMed. 54(20). 5301–9.57 indexed citations
Strayer, David S., Ellen S. Vitetta, & Heinz Köhler. (1975). Anti-receptor antibody. I. Isolation and characterization of the immunoglobulin receptor for phosphorylcholine.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 114(2 pt 2). 722–7.21 indexed citations
18.
Vitetta, Ellen S. & Jonathan W. Uhr. (1974). CELL SURFACE IMMUNOGLOBULIN. The Journal of Experimental Medicine. 139(6). 1599–1620.37 indexed citations
19.
Vitetta, Ellen S., Celso Bianco, Victor Nussenzweig, & Jonathan W. Uhr. (1972). CELL SURFACE IMMUNOGLOBULIN. The Journal of Experimental Medicine. 136(1). 81–93.127 indexed citations
20.
Vitetta, Ellen S. & Jonathan W. Uhr. (1972). CELL SURFACE IMMUNOGLOBULIN. The Journal of Experimental Medicine. 136(4). 676–696.100 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.